ReviewCurrent addiction reports2023
The Evolution of Telepsychiatry for Substance Use Disorders During COVID-19: a Narrative Review.
Review in Current addiction reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- Assessing coronavirus disease 2019 pandemic impacts on the health of people who inject drugs using a novel data sharing model.AIDS (London, England) · 2025Pooled it
- Examining the state of telehealth for mental health and substance use care after the coronavirus disease 2019 pandemic: An integrative review.The Journal of international medical research · 2026Review
- Economic cost of strategic implementation approaches to increase uptake of digital therapeutics for substance use disorders in a large integrated health system.PLOS digital health · 2026Article
- "It beats the hell out of going to a hospital": service user experiences of telemedicine-based symptom-triggered alcohol withdrawal management.Addiction science & clinical practice · 2025Article
- Telepsychiatry in Africa: overcoming barriers to access and care.Discover mental health · 2025Review
- Development and Validation of the Digital Sensitivity Scale for Adults: Cross-Sectional Observational Study.Journal of medical Internet research · 2025Observational
- Was receipt of any specialty alcohol treatment during the pandemic effective at reducing drinking for patients with or at risk of AUD?Journal of substance use and addiction treatment · 2025Article
- Telehealth to increase healthcare access; perspectives of people who use drugs.BMC medical informatics and decision making · 2024Article
- A Framework for Digital Health Policy: Insights from Virtual Primary Care Systems Across Five Nations.PLOS digital health · 2023Article
- Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping.JMIR mHealth and uHealth · 2023Article
- Mapping Factors That Affect the Uptake of Digital Therapeutics Within Health Systems: Scoping Review.Journal of medical Internet research · 2023Article
- Understanding the use intention and influencing factors of telerehabilitation in people with rehabilitation needs: a cross-sectional survey.Frontiers in public health · 2023Article
- Socio-ethical challenges and opportunities for advancing diversity, equity, and inclusion in digital medicine.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose of Review: This article aims to review and synthesize the current research evidence regarding the efficacy of telepsychiatry-delivered substance use disorder treatment using a narrative review with a focus on the effects of remote healthcare delivery within the substance abuse treatment space. Recent Findings: The COVID-19 pandemic exerted substantial pressures on all levels of society. Social isolation, loss of employment, stress, physical illness, overburdened health services, unmet medical needs, and rapidly changing pandemic restrictions had particularly severe consequences for people with mental health issues and substance use disorders. Since the start of the pandemic, addiction treatment (and medical treatment overall) using remote health platforms has significantly expanded to different platforms and delivery systems. The USA, in particular, reported transformational policy developments to enable the delivery of telehealth during the COVID-19 pandemic. However, systemic barriers such as a widespread lack of internet access and insufficient patient and provider digital skills remain. Summary: Overall, telepsychiatry is a promising approach for the treatment of substance use disorders, but more randomized controlled trials are needed in the future to assess the evidence base of available interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.